Lorenza Rimassa, MD

Articles by Lorenza Rimassa, MD
The HIMALAYA Study: STRIDE for uHCC Shows Beneficial 5-Year OS Results
Lorenza Rimassa, MDUnresectable HCC | October 4, 2024
HIMALAYA found tremelimumab plus durvalumab to significantly improve overall survival over sorafenib alone.
View More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |